Recombinant Human Erythropoietin in the Treatment of Renal Anaemia

MacDougall, Iain Cumming (1991) Recombinant Human Erythropoietin in the Treatment of Renal Anaemia. MD thesis, University of Glasgow.

Abstract

This thesis is concerned with a study of the clinical and biological effects of recombinant human erythropoietin (EPO) which recently became available as a novel treatment for the anaemia of end-stage renal disease. The dissertation begins with an introductory chapter which contains a historical note and survey of the relevant published literature. In this section is included a review of the pathogenesis of renal anaemia, the traditional treatment options for this condition, the development of recombinant human EPO, the biochemistry and physiology of erythropoietin, the metabolic fate of EPO, and the early clinical trials with EPO. This is followed by seven chapters of original work undertaken in Cardiff between April 1988 and July 1990.

• Item Type: Thesis (MD)
• Qualification Level: Doctoral
• Keywords: Medicine, Pharmacology
• Date of Award: 1991
• Depositing User: Enlighten Team
• Unique ID: glathesis:1991-77078
• Copyright: Copyright of this thesis is held by the author.
• Date Deposited: 14 Jan 2020 11:53
• Last Modified: 14 Jan 2020 11:53
• URI: https://theses.gla.ac.uk/id/eprint/77078